Table of Contents
ISRN Ophthalmology
Volume 2013 (2013), Article ID 151027, 6 pages
http://dx.doi.org/10.1155/2013/151027
Clinical Study

Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients

1Beyoglu Eye Training and Research Hospital, Bereketzade Camii Sok., Kuledibi, Beyoglu, 34421 Istanbul, Turkey
2Department of Ophthalmology, Medeniyet University, Istanbul, Turkey

Received 6 July 2013; Accepted 31 July 2013

Academic Editors: G. Fuchsjäger-Mayrl, A. Kakehashi, and H. Quiroz-Mercado

Copyright © 2013 Abdullah Ozkaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Abdullah Ozkaya, Zeynep Alkin, Yalcin Karakucuk, Dilek Yasa, Ahmet Taylan Yazici, and Ahmet Demirok, “Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients,” ISRN Ophthalmology, vol. 2013, Article ID 151027, 6 pages, 2013. doi:10.1155/2013/151027